Investment - Celularity - Additional Information - (Details) - Celularity - USD ($) $ in Millions		3 Months Ended	6 Months Ended
	Jul. 16, 2021	Jun. 30, 2022	Jun. 30, 2022
Restricted Shares
Schedule of Equity Method Investments [Line Items]
Unrealized losses on marketable investments		$ (92.8)	$ (26.1)
Private Placement Shares
Schedule of Equity Method Investments [Line Items]
Unrealized losses on marketable investments		$ (2.7)	$ (0.9)
Class A Common Stock
Schedule of Equity Method Investments [Line Items]
Common stock shares not subject to transfer restrictions		500,000	500,000
Common stock shares subject to transfer restrictions description	19,922,124 shares of Class A Common Stock of Celularity that are subject to transfer restrictions (the “Restricted Shares”). The Company also owned 500,000 shares of Class A Common Stock of Celularity not subject to transfer restrictions (the “Private Placement Shares”). During the three months ended June 30, 2022,		19,922,124 shares of Class A Common Stock of Celularity that are subject to transfer restrictions (the “Restricted Shares”).
Common stock shares not subject to transfer restrictions description			500,000 shares of Class A Common Stock of Celularity not subject to transfer restrictions (the “Private Placement Shares”)